C-peptide
- Generic Name
- C-peptide
- Drug Type
- Small Molecule
- Chemical Formula
- C129H211N35O48
- CAS Number
- 59112-80-0
- Unique Ingredient Identifier
- O2J76Y002M
- Background
C-peptide is under investigation in clinical trial NCT00278980 (Effect of C-peptide on Diabetic Peripheral Neuropathy).
Effect of C-peptide on Hypoglycemic Counterregulation
Early Phase 1
Recruiting
- Conditions
- Type 1 DiabetesHypoglycemia
- Interventions
- Other: Saline
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 38
- Registration Number
- NCT06470295
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
Effects of Canagliflozin on C-peptide Clearance in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2012-08-15
- Last Posted Date
- 2013-06-07
- Lead Sponsor
- Janssen-Cilag International NV
- Target Recruit Count
- 10
- Registration Number
- NCT01665638
Effect of C-Peptide on Diabetic Peripheral Neuropathy
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Type 1Diabetic Polyneuropathy
- First Posted Date
- 2006-01-19
- Last Posted Date
- 2006-01-19
- Lead Sponsor
- Creative Peptides Sweden Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT00278980
- Locations
- 🇸🇪
Karolinska University Hospital Solna, Stockholm, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath